Both KCNJ4 and KCNJ12 belong to the inward rectifier potassium channel family, which have been linked with cancer progression and might be valuable prognostic biomarkers and potential therapeutic targets for cancers [15, 16]. This evidence concerns the gene KCNJ4 and cancer.